The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients
Open accessAbstract
Introduction: Epithelial to mesenchymal transition (EMT) is considered an essential process in the metastatic cascade. EMT is characterised by upregulation of vimentin, Twist, Snail, Slug and Sip1 among others. Metastasis is also associated with the presence of circulating tumour cells (CTCs) and disseminated tumour cells in the blood and bone marrow, respectively, of breast cancer patients, but the expression of EMT markers in these cells has not been reported so far. Methods: The expression of Twist and vimentin in CTCs of 25 metastatic and 25 early breast cancer patients was investigated by using double-immunofluorescence experiments in isolated peripheral blood mononuclear cell cytospins using anti-cytokeratin (anti-CK) anti-mouse (A45-B/B3) and anti-Twist or anti-vimentin anti-rabbit antibodies. Results: Among early breast cancer patients, vimentin-and Twist-expressing CK+ CTCs were identified in 77% and 73% of the patients, respectively, and in 100% of the patients with metastatic breast cancer for both markers (P = 0.004 and P = 0.037, respectively). Among patients with early disease, 56% and 53% of the CK+ CTCs were double-stained with vimentin and Twist, and the corresponding values for metastatic patients were 74% and 97%, respectively (P = 0.005 and P = 0.0001, respectively). The median expression of CK+vimentin+ and CK+Twist+ cells per patient in metastatic patients was 98% and 100%, and in an adjuvant chemotherapy setting the corresponding numbers were 56% and 40.6%, respectively. Triple-staining experiments revealed that all CK+Twist+ or CK+vimentin+ cells were also CD45-, confirming their epithelial origin. Immunomagnetic separation of CTCs and triple-immunofluorescence with anti-CK/anti-Twist/anti-vimentin antibodies demonstrated that both mesenchymal markers could be coexpressed in the same CK+ cell, since 64% of the total identified CTCs were triple-stained. There was a significant correlation (P = 0.005) between the number of CTCs expressing Twist and vimentin within the same setting. Conclusions: CTCs expressing Twist and vimentin, suggestive of EMT, are identified in patients with breast cancer. The high incidence of these cells in patients with metastatic disease compared to early stage breast cancer strongly supports the notion that EMT is involved in the metastatic potential of CTCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Direct regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.140 · Cited by 1,135
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1110 · Cited by 971
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Paterlini-Brechot, P., & Benali, N. L. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.014 · Cited by 947
Aktas, B., Tewes, M., Fehm, T., Hauch, S., Kimmig, R., & Kasimir-Bauer, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2333 · Cited by 736
Rosivatz, E., Becker, I., Specht, K., Fricke, E., Luber, B., Busch, R., Höfler, H., & Becker, K.-F. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64464-1 · Cited by 572
Cheng, G. Z., Chan, J., Wang, Q., Zhang, W., Sun, C. D., & Wang, L.-H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1479 · Cited by 546
Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer
Klein, C. A., Blankenstein, T. J., Schmidt-Kittler, O., Petronio, M., Polzer, B., Stoecklein, N. H., & Riethmüller, G. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09838-0 · Cited by 479
Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target
Kwok, W. K., Ling, M.-T., Lee, T.-W., Lau, T. C. M., Zhou, C., Zhang, X., Chua, C. W., Chan, K. W., Chan, F. L., Glackin, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3785 · Cited by 468
Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas
Hoek, K., Rimm, D. L., Williams, K. R., Zhao, H., Ariyan, S., Lin, A., Kluger, H. M., Berger, A. J., Cheng, E., Trombetta, E. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0731 · Cited by 448
N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Nakajima, S., Doi, R., Toyoda, E., Tsuji, S., Wada, M., Koizumi, M., Tulachan, S. S., Ito, D., Kami, K., Mori, T., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0578-03 · Cited by 427
Expression profiling reveals novel pathways in the transformation of Melanocytes to Melanomas.
Hoek, K., Rimm, D., Williams, K., Zhao, H., Ariyan, S., Lin, A., Kluger, H., Berger, A., Cheng, E., Trombetta, E. S., et al. (2004) · Pigment Cell Research · doi:10.1111/j.1600-0749.2004.00175_12.x · Cited by 412
Epithelial–mesenchymal transition and tumour invasion
Guarino, M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.07.011 · Cited by 368
Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer
Vesuna, F., van Diest, P., Chen, J. H., & Raman, V. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.151 · Cited by 362
Stathopoulou, A., Vlachonikolis, I., Mavroudis, D., Perraki, M., Kouroussis, C., Apostolaki, S., Malamos, N., Kakolyris, S., Kotsakis, A., Xenidis, N., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.135 · Cited by 335
Self-citationFranke, W. W., Gründ, C., Jackson, B. W., & Illmensee, K. (1983) · PubMed · Cited by 318
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
Fehm, T. N., Sagalowsky, A. I., Clifford, E., Beitsch, P. D., Saboorian, H. M., Euhus, D., Meng, S., Morrison, L. E., Tucker, T. F., Lane, N., et al. (2002) · PubMed · Cited by 307
TWIST activation by hypoxia inducible factor-1 (HIF-1): Implications in metastasis and development
Yang, M.-H., & Wu, K.-J. (2008) · Cell Cycle · doi:10.4161/cc.7.14.6324 · Cited by 295
Cadherins and Catenins: Role in Signal Transduction and Tumor Progression
Behrens, J. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006200102166 · Cited by 286
Mironchik, Y., Winnard, P. T., Vesuna, F., Kato, Y., Wildes, F., Pathak, A. P., Kominsky, S., Artemov, D., Bhujwalla, Z., Van Diest, P., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0712 · Cited by 275
Raimondi, C., Gradilone, A., Naso, G., Vincenzi, B., Petracca, A., Nicolazzo, C., Palazzo, A., Saltarelli, R., Spremberg, F., Cortesi, E., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1373-x · Cited by 269
Formation of Cytoskeletal Elements During Mouse Embryogenesis
Franke, W. W., Grund, C., Kuhn, C., Jackson, B. W., & Illmensee, K. (1982) · Differentiation · doi:10.1111/j.1432-0436.1982.tb01266.x · Cited by 264
Xenidis, N., Perraki, M., Kafousi, M., Apostolaki, S., Bolonaki, I., Stathopoulou, A., Kalbakis, K., Androulakis, N., Kouroussis, C., Pallis, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5948 · Cited by 263
Self-citationEpithelial-to-Mesenchymal Transitions and Circulating Tumor Cells
Bonnomet, A., Brysse, A., Tachsidis, A., Waltham, M., Thompson, E. W., Polette, M., & Gilles, C. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9174-0 · Cited by 227
Wang, X., Ling, M. T., Guan, X.-Y., Tsao, S. W., Cheung, H. W., Lee, D. T., & Wong, Y. C. (2004) · Oncogene · doi:10.1038/sj.onc.1207128 · Cited by 220
Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion
McInroy, L., & Määttä, A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.036 · Cited by 212
Circulating tumour cells in breast cancer
Ring, A., Smith, I. E., & Dowsett, M. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01381-6 · Cited by 196
van Doorn, R., Dijkman, R., Vermeer, M. H., Out-Luiting, J. J., van der Raaij-Helmer, E. M. H., Willemze, R., & Tensen, C. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1253 · Cited by 168
Mego, M., Mani, S. A., Lee, B., Li, C., Evans, K. W., Cohen, E. N., Gao, H., Jackson, S. A., Giordano, A., Hortobagyi, G. N., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26037 · Cited by 161
Kallergi, G., Agelaki, S., Kalykaki, A., Stournaras, C., Mavroudis, D., & Georgoulias, V. (2008) · Breast Cancer Research · doi:10.1186/bcr2149 · Cited by 155
Self-citationCirculating and Disseminated Tumor Cells
Braun, S., & Naume, B. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.10.073 · Cited by 141
Kallergi, G., Markomanolaki, H., Giannoukaraki, V., Papadaki, M. A., Strati, A. D., Lianidou, E. S., Georgoulias, V., Mavroudis, D., & Agelaki, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2452 · Cited by 140
Self-citationBozionellou, V., Mavroudis, D., Perraki, M., Papadopoulos, S., Apostolaki, S., Stathopoulos, E. N., Stathopoulou, A., Lianidou, E. S., & Georgoulias, V. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0094 · Cited by 128
Self-citationTHOMAS, P. A., Kirschmann, D. A., Cerhan, J. R., Folberg, R., Seftor, E. A., Sellers, T. A., & Hendrix, M. J. C. (1999) · PubMed · Cited by 126
Bidard, F., Vincent‐Salomon, A., Sigal‐Zafrani, B., Dieras, V. C., Mathiot, C., Mignot, L., Thiery, J. P., Sastre‐Garau, X., & Pierga, J. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm507 · Cited by 124
Vimentin affects the mobility and invasiveness of prostate cancer cells
Zhao, Y., Yan, Q., Long, X., Chen, X., & Wang, Y. (2008) · Cell Biochemistry and Function · doi:10.1002/cbf.1478 · Cited by 122
Expression of twist and wnt in human breast cancer.
Watanabe, O., Imamura, H., Shimizu, T., Kinoshita, J., Okabe, T., Hirano, A., Yoshimatsu, K., Konno, S., Aiba, M., & Ogawa, K. (2004) · PubMed · Cited by 117
Watson, M. A., Ylagan, L. R., Trinkaus, K. M., Gillanders, W. E., Naughton, M. J., Weilbaecher, K. N., Fleming, T. P., & Aft, R. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0024 · Cited by 115
Fehm, T. N., Solomayer, E., Meng, S., Tucker, T. F., Lane, N., Wang, J., & Gebauer, G. (2005) · Cytotherapy · doi:10.1080/14653240510027082 · Cited by 112
Kallergi, G., Mavroudis, D., Georgoulias, V., & Stournaras, C. (2007) · Molecular Medicine · doi:10.2119/2006-00083.kallergi · Cited by 88
Self-citationFrequent genomic abnormalities at TWIST in human pediatric osteosarcomas
Entz‐Werlé, N., Stoetzel, C., Marec‐Bérard, P., Kalifa, C., Brugière, L., Pacquement, H., Schmitt, C., Tabone, M., Gentet, J., Quillet, R., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21068 · Cited by 78
Zhang, X., Wang, Q., Ling, M., Wong, Y. C., Leung, S. C. L., & Wang, X. (2007) · International Journal of Cancer · doi:10.1002/ijc.22489 · Cited by 67
Pagan, R., Martı́n, I., Alonso‐Varona, A., Llobera, M., & Vilaró, S. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0043 · Cited by 56
Bartkowiak, K., Wieczorek, M., Buck, F., Harder, S., Moldenhauer, J., Effenberger, K. E., Pantel, K., Peter‐Katalinić, J., & Brandt, B. (2009) · Journal of Proteome Research · doi:10.1021/pr8009758 · Cited by 50
Cited by
Epithelial–mesenchymal plasticity in carcinoma metastasis
Tsai, J. H., & Yang, J. (2013) · Genes & Development · doi:10.1101/gad.225334.113 · Cited by 1,136
Tsai, J. H., Donaher, J. L., Murphy, D. A., Chau, S., & Yang, J. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.09.022 · Cited by 1,071
Circulating tumor cells: biology and clinical significance
Lin, D., Shen, L., Luo, M., Zhang, K., Li, J., Yang, Q., Zhu, F., Zhou, D., Zheng, S., Chen, Y., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00817-8 · Cited by 993
Epithelial–mesenchymal transition in tumor metastasis
Yeung, K. T., & Yang, J. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12017 · Cited by 723
Molecular analysis of circulating tumour cells—biology and biomarkers
Krebs, M. G., Metcalf, R. L., Carter, L., Brady, G., Blackhall, F. H., & Dive, C. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.253 · Cited by 622
Metadata
- Authors
- Kallergi, G., Papadaki, M. A., Politaki, E., Mavroudis, D., Georgoulias, V., & Agelaki, S.
- Venue
- Breast Cancer Research
- Published
- 2011-06
- Volume
- 13
- Issue
- 3
- Pages
- R59-R59
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W2103736766
- Cited by
- 377
- References
- 47
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.